Shapuai Si: Obtained the Drug Registration Certificate for Citrate Sildenafil Orally Disintegrating Tablets

Shapu Aisi Announcement, recently, the company received the "Drug Registration Certificate" (Certificate No.: 2026S01571) issued by the National Medical Products Administration for Citrate Sildenafil Orally Disintegrating Tablets.
The approved Citrate Sildenafil Orally Disintegrating Tablets are used to treat erectile dysfunction.
As of the date of this announcement, the company's total R&D investment in this drug is approximately 9.91M RMB.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned